Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis
- PMID: 21070859
- PMCID: PMC3031720
- DOI: 10.1016/j.micinf.2010.10.022
Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis
Abstract
Francisella tularensis is a category A select agent based on its infectivity and virulence but disease mechanisms in infection remain poorly understood. Murine pulmonary models of infection were therefore employed to assess and compare dissemination and pathology and to elucidate the host immune response to infection with the highly virulent Type A F. tularensis strain Schu4 versus the less virulent Type B live vaccine strain (LVS). We found that dissemination and pathology in the spleen was significantly greater in mice infected with F. tularensis Schu4 compared to mice infected with F. tularensis LVS. Using gene expression profiling to compare the response to infection with the two F. tularensis strains, we found that there were significant differences in the expression of genes involved in the apoptosis pathway, antigen processing and presentation pathways, and inflammatory response pathways in mice infected with Schu4 when compared to LVS. These transcriptional differences coincided with marked differences in dissemination and severity of organ lesions in mice infected with the Schu4 and LVS strains. Therefore, these findings indicate that altered apoptosis, antigen presentation and production of inflammatory mediators explain the differences in pathogenicity of F. tularensis Schu4 and LVS.
Copyright © 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.
Figures
References
-
- Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O’Toole T, Parker G, Perl TM, Russell PK, Tonat K. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285:2763–2773. - PubMed
-
- Petersen JM, Schriefer ME. Tularemia: emergence/re-emergence. Vet Res. 2005;36:455–467. - PubMed
-
- Edwin LO, Tigertt WD, Paul JK, Martha KW, Charkes ND, Robert MR, Theodore ES, Mallory S. An analysis of forty-two cases of laboratory-acquired tularemia: Treatment with broad spectrum antibiotics. The American journal of medicine. 1961;30:785–806. - PubMed
-
- Chocarro A, Gonzalez A, Garcia I. Treatment of Tularemia with Ciprofloxacin. Clinical Infectious Diseases. 2000;31:623–623. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
